Chemical Works of Gedeon Richter Plc (RGEDF)
43.45
-0.31
(-0.71%)
USD |
OTCM |
Aug 26, 16:00
Chemical Works of Gedeon Richter Shareholders Equity (Quarterly) : 4.366B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.366B |
| March 31, 2026 | 4.349B |
| December 31, 2025 | 4.278B |
| September 30, 2025 | 4.019B |
| June 30, 2025 | 3.815B |
| March 31, 2025 | 3.596B |
| December 31, 2024 | 3.274B |
| September 30, 2024 | 3.441B |
| June 30, 2024 | 3.174B |
| March 31, 2024 | 3.248B |
| December 31, 2023 | 3.268B |
| September 30, 2023 | 2.954B |
| June 30, 2023 | 3.039B |
| March 31, 2023 | 3.109B |
| December 31, 2022 | 2.834B |
| September 30, 2022 | 2.537B |
| June 30, 2022 | 2.656B |
| March 31, 2022 | 2.862B |
| December 31, 2021 | 2.823B |
| September 30, 2021 | 2.788B |
| June 30, 2021 | 2.769B |
| March 31, 2021 | 2.710B |
| December 31, 2020 | 2.722B |
| September 30, 2020 | 2.544B |
| June 30, 2020 | 2.437B |
| Date | Value |
|---|---|
| March 31, 2020 | 2.274B |
| December 31, 2019 | 2.437B |
| September 30, 2019 | 2.409B |
| June 30, 2019 | 2.501B |
| March 31, 2019 | 2.472B |
| December 31, 2018 | 2.424B |
| September 30, 2018 | 2.502B |
| June 30, 2018 | 2.459B |
| March 31, 2018 | 2.656B |
| December 31, 2017 | 2.552B |
| September 30, 2017 | 2.647B |
| June 30, 2017 | 2.511B |
| March 31, 2017 | 2.427B |
| December 31, 2016 | 2.307B |
| September 30, 2016 | 2.364B |
| June 30, 2016 | 2.249B |
| March 31, 2016 | 2.285B |
| December 31, 2015 | 2.121B |
| September 30, 2015 | 2.157B |
| June 30, 2015 | 2.153B |
| March 31, 2015 | 2.094B |
| December 31, 2014 | 2.141B |
| September 30, 2014 | 2.334B |
| June 30, 2014 | 2.514B |
| March 31, 2014 | 2.515B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| AstraZeneca PLC | 47.33B |
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
| Avadel Pharmaceuticals Plc | 98.22M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.432B |
| Total Liabilities (Quarterly) | 1.058B |
| Debt to Equity Ratio | 0.0141 |
| Current Ratio | 3.786 |
| Net Debt Paydown Yield | -0.01% |